刊名:Journal of Cancer Research and Clinical Oncology
出版年:2009
出版时间:December, 2009
年:2009
卷:135
期:12
页码:1647-1654
全文大小:358.7 KB
文摘
Purpose Although epidermal growth factor receptor (EGFR) tyrosine kinase (TK) mutations are highly predictive of response to EGFR TK inhibitors in advanced non-small-cell lung cancer (NSCLC), a prognostic value of EGFR mutations in resected NSCLC has not been established.